Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

Emanuele Pontali¹, Giovanni Sotgiu², Lia D'Ambrosio³, Rosella Centis⁴, Giovanni Battista Migliori⁴

Affiliations

¹ Dept of Infectious Diseases, Galliera Hospital, Genova, Italy Both authors contributed equally.
² Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences - University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy Both authors contributed equally giovannibattista.migliori@fsm.it.
³ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland.
⁴ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.

PMID: 26828052
DOI: 10.1183/13993003.01891-2015

Free article

Editorial

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

Emanuele Pontali et al. Eur Respir J. 2016 Feb.

Free article

. 2016 Feb;47(2):394-402.

doi: 10.1183/13993003.01891-2015.

Authors

Emanuele Pontali¹, Giovanni Sotgiu², Lia D'Ambrosio³, Rosella Centis⁴, Giovanni Battista Migliori⁴

Affiliations

¹ Dept of Infectious Diseases, Galliera Hospital, Genova, Italy Both authors contributed equally.
² Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences - University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy Both authors contributed equally giovannibattista.migliori@fsm.it.
³ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland.
⁴ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.

PMID: 26828052
DOI: 10.1183/13993003.01891-2015

No abstract available

PubMed Disclaimer

Comment in

Paediatric study of bedaquiline remains an "open issue".
McKenna L, Ruiz Mingote L. McKenna L, et al. Eur Respir J. 2016 Sep;48(3):956-7. doi: 10.1183/13993003.00628-2016. Eur Respir J. 2016. PMID: 27581412 No abstract available.
New anti-tuberculosis drugs for special populations: a difficult-to-address issue.
Sotgiu G, Pontali E, Centis R, D'Ambrosio L, Migliori GB. Sotgiu G, et al. Eur Respir J. 2016 Sep;48(3):957-8. doi: 10.1183/13993003.01289-2016. Eur Respir J. 2016. PMID: 27581413 No abstract available.

Comment on

Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
Pym AS, Diacon AH, Tang SJ, Conradie F, Danilovits M, Chuchottaworn C, Vasilyeva I, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, Van Baelen B, van Heeswijk RP, Dannemann B; TMC207-C209 Study Group. Pym AS, et al. Eur Respir J. 2016 Feb;47(2):564-74. doi: 10.1183/13993003.00724-2015. Epub 2015 Dec 2. Eur Respir J. 2016. PMID: 26647431 Clinical Trial.

Cited by

Mitochondrial dysfunction induced by bedaquiline as an anti-Toxoplasma alternative.
Shi Y, Jiang Y, Qiu H, Hu D, Song X. Shi Y, et al. Vet Res. 2023 Dec 19;54(1):123. doi: 10.1186/s13567-023-01252-z. Vet Res. 2023. PMID: 38115043 Free PMC article.
Development of New Preventive and Therapeutic Vaccines for Tuberculosis.
Kwon BE, Ahn JH, Min S, Kim H, Seo J, Yeo SG, Ko HJ. Kwon BE, et al. Immune Netw. 2018 Apr 3;18(2):e17. doi: 10.4110/in.2018.18.e17. eCollection 2018 Apr. Immune Netw. 2018. PMID: 29732235 Free PMC article. Review.
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.
Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Ranganathan UDK, McNerney R, Ezewudo M, Cirillo DM, Schito M, Köser CU, Rodwell TC. Miotto P, et al. Eur Respir J. 2017 Dec 28;50(6):1701354. doi: 10.1183/13993003.01354-2017. Print 2017 Dec. Eur Respir J. 2017. PMID: 29284687 Free PMC article.
Transmission of drug-resistant tuberculosis in HIV-endemic settings.
Khan PY, Yates TA, Osman M, Warren RM, van der Heijden Y, Padayatchi N, Nardell EA, Moore D, Mathema B, Gandhi N, Eldholm V, Dheda K, Hesseling AC, Mizrahi V, Rustomjee R, Pym A. Khan PY, et al. Lancet Infect Dis. 2019 Mar;19(3):e77-e88. doi: 10.1016/S1473-3099(18)30537-1. Epub 2018 Dec 13. Lancet Infect Dis. 2019. PMID: 30554996 Free PMC article. Review.
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in Mycobacterium tuberculosis.
Khonde LP, Müller R, Boyle GA, Reddy V, Nchinda AT, Eyermann CJ, Fienberg S, Singh V, Myrick A, Abay E, Njoroge M, Lawrence N, Su Q, Myers TG, Boshoff HIM, Barry CE 3rd, Sirgel FA, van Helden PD, Massoudi LM, Robertson GT, Lenaerts AJ, Basarab GS, Ghorpade SR, Chibale K. Khonde LP, et al. J Med Chem. 2021 Sep 9;64(17):12790-12807. doi: 10.1021/acs.jmedchem.1c00837. Epub 2021 Aug 20. J Med Chem. 2021. PMID: 34414766 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

Affiliations

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources